News from WCM

Microbes in the mammalian gut can significantly change their hosts’ amino acid and glucose metabolism, acting almost like an extra liver, according to a new preclinical study by Weill Cornell Medicine investigators.

Dr. Adam D. Cheriff, a physician and healthcare executive with more than 20 years of leadership experience, has been named the new chief operating officer of Weill Cornell Medicine's Physician Organization, effective May 1. 

Dr. Carl Nathan, chair of the department of microbiology and immunology and the R.A. Rees Pritchett Professor of Microbiology at Weill Cornell Medicine, answers questions about interferon-γ's history and future.

Dr. C. Noel Bairey Merz delivered a keynote address entitled “Sex and Gender Medicine: Science, Policy and Health Disparities in CVD,” as part of Weill Cornell Medicine's sixth annual Diversity Week.

Weill Cornell Medicine’s Celebration of Diversity, part of the institution’s sixth annual Diversity Week, was held on April 15. The awardees were honored for their commitment to diversity and inclusivity in academic medicine through exemplary contributions in mentorship, research, clinical care, community service and advocacy.

To imagine a society without racial disparities in health care, we must consider the real reasons inequities exist, said Dr. Thomas LaVeist in his keynote address on April 15 for Weill Cornell Medicine’s sixth annual Diversity Week.

Weill Cornell Medicine investigators have uncovered a way to unleash in blood vessels the protective effects of a type of fat-related molecule known as a sphingolipid, suggesting a promising new strategy for the treatment of coronary artery disease.

Launched in 2019, the IMSD Program aims to boost admissions and retention rates of doctoral students primarily from self-identified historically underrepresented groups in science. 

Researchers at Weill Cornell Medicine have developed a powerful, new technique to generate “movies” of changing protein structures at speeds of up to 50 frames per second.

Treatment for rheumatoid arthritis (RA) has come a long way in recent years. In many cases, a battery of...

Investigators at Weill Cornell Medicine have assembled the most comprehensive atlas to date of messenger RNA (mRNA) variants in the mouse and human brain, which will be important in understanding brain development, neuron specialization and other brain functions.

A clinical trial led by Weill Cornell Medicine investigators showed that a nasal spray that patients administer at home, without a physician, successfully and safely treated recurrent episodes of a condition that causes rapid abnormal heart rhythms. 

Women are at higher risk of death when undergoing heart bypass surgery than men. Researchers at Weill Cornell Medicine have determined that this disparity is mediated, to a large extent, by intraoperative anemia—the dilution of red blood cells during surgery.

Weill Cornell Medicine scientists have developed an innovative human neuron model that robustly simulates the spread of tau protein aggregates in the brain—a process that drives cognitive decline in Alzheimer's disease and frontotemporal dementia. 

Using state-of-the-art tissue engineering techniques and a 3D printer, researchers at Weill Cornell Medicine and Cornell Engineering have assembled a replica of an adult human ear that looks and feels natural.

A team led by researchers at Weill Cornell Medicine has identified important drivers of the transformation of a type of blood cancer called follicular lymphoma from a slow-growing form to the aggressive form it takes in some patients.

Researchers at Weill Cornell Medicine have discovered a protein that plays a critical role in clearing collagen from tissue and may be a therapeutic target to help prevent fibrosis, scar tissue that interferes with organ function.

The 2024 Health Hackathon brought together 185 students with diverse backgrounds from Cornell and 26 other universities—in just 36 hours, they addressed critical safety challenges facing patients today.

Individuals with physical health concerns made up the largest and fastest growing of five subgroups of individuals who died by suicide in the United States over roughly twenty years, according to an analysis led by Weill Cornell Medicine in collaboration with Columbia University, UC Berkeley School of Public Health, the University of Hong Kong and University of Kentucky investigators.

A collaboration between Dr. Jedd Wolchok, the Meyer Director of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine, and Dr. Yelena Janjigian, chief of the gastrointestinal oncology service at Memorial Sloan Kettering Cancer Center, is looking to transform the care of gastroesophageal cancer (GEC) patients with untreatable disease – earning the pair a grant from Stand Up To Cancer® (SU2C) as a part of the SU2C-Torrey Coast Foundation Gastroesophageal Cancer Dream Team Collective.